Approxima secured a € 7.3M Series A financing round in the first closing. to support advancement of a percutaneous right ventricular reshaping technology to treat patients with tricuspid valve regurgitation

Milan, Italy, February 20, 2025 – Approxima Srl announced today the first closing of a Series A financing round securing € 7.3M. The round was co-lead by ENEA Tech e Biomedical and Panakès Partners with strong continued support from current shareholders Club degli Investitori and other business angels. The round remains open for subscription from other co-investors in the coming months. Concurrent with the financing, Chiara Vieceli, international industry expert in the cardiovascular sector, has joined as a member of the Board of Directors and further expansion of the Board is underway.
Download press release